Clinical Trial Update: Evaluation of the Effect of Pramlintide on Satiety and Food Intake [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of pramlintide on satiety and food intake in adults with Type 1 or Type 2 diabetes. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Symlin (pramlintide)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED